DIZAL (JIANGSU) PHARMACEUTICAL CO L financial statements, including revenue, expenses, and profit
The total revenue of 688192 for the last quarter is 21.94 M CNY, and it's 83.68% lower compared to the previous quarter. The net income of Q4 24 is -207.12 M CNY.